查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520580

2024-2032 年静脉曲张治疗市场报告（按产品、程序、最终用户和地区）

Varicose Vein Treatment Market Report by Product, Procedure, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球静脉曲张治疗市场规模达4.38亿美元。老年人口的不断增长、微创（MI）手术的技术进步、意识和医疗保健支出的提高，以及专注于创新和战略合作以扩大治疗选择和地理覆盖范围的主要参与者是推动市场增长的一些因素。

静脉曲张治疗市场分析：

主要市场驱动因素：由于老龄化人口中静脉曲张盛行率的上升以及治疗技术的进步，市场正在经历适度增长。

主要市场趋势：与传统手术方法相比，由于微创治疗方法疗效显着、疼痛减轻且恢復时间更短，人们正在转向微创治疗方法。除此之外，影像技术在静脉曲张治疗中的不断集成，提高了治疗和结果的精确度，也促进了市场的成长。

地理趋势：由于高额医疗支出、先进的医疗基础设施以及大众对静脉曲张疾病的认识不断提高，北美在市场上占据主导地位。

竞争格局：静脉曲张治疗产业的一些主要市场参与者包括 Alma Lasers Ltd. (Sisram Medical Ltd.)、Angiodynamics Inc.、Biolitec AG (BioMed Technology Holdings Ltd.)、Boston Scientific Corporation、Eufoton SRL、Fotona、 Medtronic plc 、Sciton Inc.、Teleflex Incorporated、The Vein Company、VVT Medical Ltd. 和WON TECH Co. Ltd. 等。

挑战与机会：先进静脉曲张治疗的成本不断增加，这对于没有足够保险覆盖的患者来说可能令人望而却步，特别是在欠发达地区，这正在影响市场收入。儘管如此，这也为行业参与者创造了开发负担得起的解决方案的机会，从而增加了更广泛人群获得治疗的机会。此外，获得更多有关健康的知识是静脉曲张治疗市场最近的主要发展之一，可以告知潜在患者各种治疗选择，扩大潜在客户群。

静脉曲张治疗市场趋势：

治疗技术进步

静脉注射雷射治疗 (EVLT)、射频消融 (RFA) 和超音波导引硬化疗法等不断取得的进步正在改变治疗方法，从侵入性手术转向微创 (MI) 和非手术选择。对于患者来说，此类新技术有望实现更快的恢復、更少的疼痛以及更少的术后併发症发生机会，这使得手术越来越受欢迎。 2023年，全球微创手术市场规模为529亿美元。根据IMARC Group的报告，预计到 2032 年，市场规模将达到 910 亿美元，2024-2032 年复合年增长率为 6%。雷射和射频设备的进一步发展与成像技术相结合，可以对患病静脉进行更精确的治疗，从而推动了静脉曲张治疗的需求。公司正在将其收入用于研发（R＆D），以充分利用现有技术并提出新的创新。

医疗保健全球化

透过国际合作，医疗保健专业人员交流最佳实践和技术，提高全球治疗品质。例如，继2023 年6 月获得FDA 批准后，VVT Medical 宣布与Methapharm 达成策略性分销协议，在美国销售其ScleroSafe 平台。非热、非-肿胀技术。这种全球性的交流保证了不同地区可以使用先进的治疗技术和标准化的护理质量，支持静脉曲张治疗市场的成长。医疗旅游也是一个因素，患者出国旅行以更实惠的价格寻求一流的治疗。 2023年，全球医疗旅游产业价值达1,197亿美元。 IMARC Group估计，从2024 年到2032 年，市场将以20.1% 的复合年增长率扩张，到2032 年达到6508 亿美元。和技术进步。

监管部门的批准和支持

获得监管部门的批准和支持对于推动静脉曲张治疗的发展至关重要。监管机构为新的医疗器材和治疗方法制定严格的标准并提供明确的审批程序。严格的监管环境促使公司投资研究和临床试验以推动创新。当局批准治疗可以在医疗保健提供者和患者之间建立信任和信心，确保市场上有安全有效的选择。此外，强有力的监管可以加速尖端治疗方法进入市场，加快其采用并扩大现代静脉曲张治疗选择的范围。 2024年4月，VVT Medical的ScleroSafe™设备获得韩国食品药物安全部的批准，在韩国市场实现了一个重要里程碑。这是在获得 FDA 510(k) 许可和 CE 标誌之后，确认 ScleroSafe(TM) 是静脉曲张治疗的可靠选择。

静脉曲张治疗市场细分：

IMARC Group对每个细分市场的主要静脉曲张治疗市场趋势进行了分析，并对 2024-2032 年全球、区域和国家层面进行了预测。我们的报告根据产品、程序和最终用户对市场进行了分类。

按产品划分：

消融装置

射频消融设备

雷射烧蚀装置

其他的

硬化剂注射

其他的

该报告根据产品提供了详细的市场细分和分析。这包括消融设备（射频消融设备、雷射消融设备等）、硬化剂注射等。

消融设备是一个重要的部分，尤其是射频和雷射消融设备，因为它们是治疗静脉曲张的首选。这些方法可以有效地封闭有问题的静脉，其侵入性比迄今为止使用的方法要小，从而减轻疼痛并让患者快速康復。射频消融设备利用热能来加热和塌陷静脉，而雷射消融则利用光能来实现类似的结果，为喜欢微创治疗的患者提供了有效的选择。 2023年，全球消融器械市场规模达59亿美元。 IMARC Group预测，到 2032 年，该市值将达到 144 亿美元，2024 年至 2032 年复合年增长率为 10.2%。

硬化剂注射剂在产业中占有稳固的地位，进而影响静脉曲张治疗市场的收入。该技术包括将溶液注射到曲张静脉中，导致疤痕并将血液重新引导到更健康的静脉，最终导致治疗后的静脉消失。使用该技术是因为它可以有效地治疗轻微静脉曲张和蜘蛛网状静脉，并且易于使用且成本合理。它在门诊环境中特别受欢迎，因为快速恢復是一个重要因素。

其他包括一系列额外的选择，例如压力袜和外科手术。压力袜通常用作非手术方法来控制症状并延缓静脉曲张的进展，特别是在初始阶段或轻度情况下。儘管由于微创 (MI) 技术的增加，现在较少使用外科手术，但在其他治疗方法不起作用的严重情况下，仍会使用外科手术。该部分服务于广泛的患者，提供从基本预防护理到广泛手术治疗的选择。

依程序分解：

注射硬化疗法

静脉内消融

手术结扎和剥离

注射硬化疗法占业界最大份额

报告还提供了基于程序的详细市场细分和分析。这包括注射硬化疗法、静脉内消融以及手术结扎和剥离。报告称，注射硬化疗法占据最大的市场份额。

注射硬化疗法是静脉曲张治疗产业中最主要的领域，主要是因为其有效性、低侵入性和成本效益。该过程包括将硬化剂溶液注射到曲张静脉中，刺激静脉壁，导致静脉塌陷和黏合。随着时间的推移，经过治疗的静脉会被周围组织吸收，逐渐消失。硬化疗法的受欢迎程度因其能够在门诊环境中进行、能够快速解决美容问题以及小静脉曲张和蜘蛛静脉引起的不适以及恢復时间短而得到增强，使其成为既希望有效又方便的患者的首选。 2023年，全球硬化疗法市场价值12亿美元。 IMARC Group预计，从 2024 年到 2032 年，该市场将以 5.5% 的年复合成长率(CAGR) 扩张，到 2032 年将达到 20 亿美元。

按最终用户划分：

医院

诊所

门诊中心

医院代表领先的细分市场

该报告提供了基于最终用户的详细市场细分和分析。这包括医院、诊所和门诊中心。报告称，医院占最大部分。

医院因其广泛的治疗选择和处理需要先进医疗干预的复杂病例的能力而主导市场，塑造了积极的静脉曲张治疗市场前景。他们拥有提供各种类型静脉曲张治疗所需的基础设施，包括硬化疗法和静脉内消融等侵入性较小的手术，以及手术结扎和剥离等更具侵略性的技术。对于正在寻求专业血管外科医生和介入放射科医生可靠且有效治疗的患者来说，本部分将增强他们的信心。此外，医院往往是晚期静脉曲张患者的首选，这些患者可能需要各种医疗保健提供者的全面护理和长期监测，从而巩固了其在市场中的地位。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的静脉曲张治疗市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是静脉曲张治疗的最大区域市场。

北美在市场上占有最大份额，主要是由于大量的医疗保健支出、尖端的医疗技术和健全的医疗保健系统。该地区涵盖美国和加拿大，由于老年居民中有大量静脉曲张，因此对微创 (MI) 手术的需求很高。根据 2023 年美国人口普查局的报告，美国 65 岁及以上人口的数量预计将从 2022 年的 5800 万增加到 2050 年的 8200 万，增长 47%。 23%。此外，北美还拥有顶尖的医疗保健公司和鼓励快速采用新技术的强大监管框架。该地区在全球市场上的强大影响力也得益于其广泛的保险覆盖范围和高度的患者意识。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。该行业的一些主要市场参与者包括 Alma Lasers Ltd. (Sisram Medical Ltd.)、Angiodynamics Inc.、Biolitec AG (BioMed Technology Holdings Ltd.)、Boston Scientific Corporation、Eufoton SRL、Fotona、Medtronic plc、Sciton Inc.。 、 Teleflex Incorporated、The Vein Company、VVT Medical Ltd. 和WON TECH Co. Ltd.

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

市场主要参与者正在努力进行研发 (R&D)，以提高目前治疗的效率和安全性，并寻求新解决方案的批准。领先的静脉曲张治疗公司正致力于透过建立策略合作伙伴关係、合併和收购其他公司来扩大其产品范围，以加强其全球市场地位。例如，DXI Capital Corp.于2023年11月24日透露，计划透过一份不具约束力的意向书收购VVT Med Ltd.和Exiteam Acquisition Corp.的全部股份。此举旨在帮助 DXI 满足 TSX Venture Exchange 的上市标准并维持 VVT 的静脉曲张治疗业务。此外，也大力关注行销和教育活动，以提高医疗保健提供者和患者对静脉曲张治疗进展的认识。这些措施的重点是促进现代和侵入性较小的疗法的使用，扩大市场上的治疗选择。

静脉曲张治疗市场新闻：

2023 年 9 月：FDA 批准了 VVT Medical 的 ScleroSafe 平台，用于在不使用热或肿胀方法的情况下治疗浅静脉曲张。该小工具已在多个领域获得批准，可使用具有反向作用的双注射器同时管理和清除物质。

本报告回答的关键问题：

  • 迄今为止，全球静脉曲张治疗市场表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和静脉曲张治疗市场近期的机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的市场？
  • 基于产品的市场区隔是什么？
  • 市场上最有吸引力的产品是什么？
  • 市场分類的程序是什么？
  • 市场上最有吸引力的程序是什么？
  • 基于最终用户的市场区隔是什么？
  • 哪个是市场上最具吸引力的最终用户？
  • 市场竞争结构如何？
  • 谁是全球静脉曲张治疗市场的主要参与者/公司？

本报告回答的关键问题：

  • 迄今为止，全球静脉曲张治疗市场表现如何，未来几年将如何表现？
  • 全球市场的驱动因素、限制因素和静脉曲张治疗市场近期的机会是什么？
  • 每个驱动因素、限制因素和机会对全球市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的市场？
  • 基于产品的市场区隔是什么？
  • 市场上最有吸引力的产品是什么？
  • 市场分類的程序是什么？
  • 市场上最有吸引力的程序是什么？
  • 基于最终用户的市场区隔是什么？
  • 哪个是市场上最具吸引力的最终用户？
  • 市场竞争结构如何？
  • 谁是全球静脉曲张治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球静脉曲张治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 消融装置
    • 市场走向
    • 关键环节
      • 射频消融设备
      • 雷射烧蚀装置
      • 其他的
    • 市场预测
  • 硬化剂注射
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按程序

  • 注射硬化疗法
    • 市场走向
    • 市场预测
  • 静脉内消融
    • 市场走向
    • 市场预测
  • 手术结扎和剥离
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 门诊中心
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Alma Lasers Ltd. (Sisram Medical Ltd.)
    • Angiodynamics Inc.
    • Biolitec AG (BioMed Technology Holdings Ltd.)
    • Boston Scientific Corporation
    • Eufoton SRL
    • Fotona
    • Medtronic plc
    • Sciton Inc.
    • Teleflex Incorporated
    • The Vein Company
    • VVT Medical Ltd.
    • WON TECH Co. Ltd
Product Code: SR112024A5494

The global varicose vein treatment market size reached US$ 438.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 670.8 Million by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032. The growing elderly population, technological advancements in minimally invasive (MI) procedures, increasing awareness and healthcare spending, and key players focusing on innovation and strategic collaborations to expand treatment options and geographic reach are some of the factors impelling the market growth.

Varicose Vein Treatment Market Analysis:

Major Market Drivers: The market is experiencing moderate growth because of the rising prevalence of varicose veins among the aging population and advancements in treatment technologies.

Key Market Trends: There is a shift towards less invasive treatment methods because of their efficacy, reduced pain, and shorter recovery periods compared to traditional surgical methods. Besides this, the growing integration of imaging technologies in varicose vein treatments, which enhances the precision of treatments and outcomes, is contributing to the growth of the market.

Geographical Trends: North America dominates the market, driven by high healthcare expenditure, advanced medical infrastructure, and increasing awareness about varicose vein conditions among the masses.

Competitive Landscape: Some of the major market players in the varicose vein treatment industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd., among many others.

Challenges and Opportunities: The growing cost of advanced varicose vein treatments, which can be prohibitive for patients without adequate insurance coverage, particularly in less developed regions, is influencing the market revenue. Nevertheless, this also creates a chance for industry participants to develop affordable solutions that can increase the availability of treatments to a wider range of people. Moreover, gaining more knowledge about health presents one of the major varicose vein treatment market recent developments to inform potential patients about the various treatment options, broadening the potential customer base.

Varicose Vein Treatment Market Trends:

Technological Advancements in Treatment

Ongoing advancements like endovenous laser therapy (EVLT), radiofrequency ablation (RFA), and ultrasound-guided sclerotherapy are changing treatment approaches from invasive surgeries to minimally invasive (MI) and non-surgical options. For patients, such new technologies promise quicker recovery, less pain, and smaller chances of post-operation complications, which is causing the popularity of the surgeries to grow. In 2023, the size of the global minimally invasive surgery market was US$ 52.9 Billion. As per the report by the IMARC Group, the market is expected to reach US$ 91.0 Billion by 2032, exhibiting a CAGR of 6% during 2024-2032. Further development of lasers and radiofrequency devices in combination with imaging technologies for more pinpoint treatment in the ailing veins is driving the varicose vein treatment demand. Companies are channelizing their revenues for research and development (R&D) to make the best use of technologies existing and to come up with new innovations.

Globalization of Healthcare

By partnering internationally, healthcare professionals exchange best practices and technologies, enhancing the quality of treatment globally. For instance, VVT Medical announced a strategic distribution agreement with Methapharm to market its ScleroSafe platform in the USA, following FDA approval in June 2023. This collaboration leverages Methapharm's expertise in varicose veins, aiming to transform treatment with ScleroSafe's innovative, non-thermal, non-tumescent technique. This worldwide exchange guarantees that advanced treatment techniques are available in different areas with standardization of care quality, supporting the varicose vein treatment market growth. Medical tourism is also a factor, with patients traveling overseas in search of top-notch treatments at more affordable prices. In 2023, the medical tourism industry in the world was valued at US$119.7 billion. The IMARC Group estimates the market would expand at a CAGR of 20.1% from 2024 to 2032, reaching US$ 650.8 billion in 2032. Globalization leads to increased accessibility and improved quality of varicose vein treatments worldwide, supporting market expansion and technological progress.

Regulatory Approvals and Support

Obtaining regulatory approvals and support is essential for advancing the development of varicose vein treatment. Regulatory agencies establish stringent criteria and provide clear approval procedures for new medical devices and treatments. The strict regulatory landscape motivates companies to invest in research and clinical trials to drive innovation. The approval of treatments by authorities builds trust and confidence between healthcare providers and patients, guaranteeing the presence of secure and efficient choices in the market. Furthermore, robust regulations can accelerate the entry of cutting-edge treatments into the market, quickening their adoption and expanding the range of modern options for varicose vein treatment. In April 2024, VVT Medical achieved a major milestone in the Korean market with the approval of its ScleroSafe(TM) device by the Korean Ministry of Food and Drug Safety. This was after the FDA 510(k) clearance and CE Mark, confirming ScleroSafe(TM) as a dependable option for varicose vein treatment.

Varicose Vein Treatment Market Segmentation:

IMARC Group provides an analysis of the key varicose vein treatment market trends in each segment, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, procedure, and end user.

Breakup by Product:

Ablation Devices

Radiofrequency Ablation Devices

Laser Ablation Devices

Others

Sclerotherapy Injection

Others

The report has provided a detailed breakup and analysis of the market based on the product. This includes ablation devices (radiofrequency ablation devices, laser ablation devices, and others), sclerotherapy injection, and others.

Ablation devices are an important segment, especially radiofrequency and laser ablation devices, because they are preferred in the treatment of varicose veins. These are effective in shutting off problematic veins with ways that are less invasive than those used hitherto, thereby inflicting less pain and delivering the patient to recovery quickly. Radiofrequency ablation devices utilize thermal energy to heat and collapse the vein, while laser ablation uses light energy to accomplish similar outcomes, providing effective options for patients who prefer less invasive treatments. In 2023, the market size of ablation devices worldwide reached US$ 5.9 billion. IMARC Group forecasts that the market will reach a value of US$ 14.4 billion by 2032, showing a 10.2% CAGR from 2024 to 2032.

Sclerotherapy injections have a solid presence in the industry, thereby influencing the varicose vein treatment market revenue. This technique includes injecting a solution into the varicose veins, which results in scarring and redirecting blood to healthier veins, ultimately causing the treated vein to vanish. The technique is used because of its effectiveness in addressing minor varicose veins and spider veins, its ease of use, and its reasonable cost. It is particularly popular in outpatient settings, where fast recovery is an important factor.

Others encompass a range of additional options, such as compression stockings and surgical procedures. Compression stockings are often utilized as a non-surgical method to control symptoms and delay the advancement of varicose veins, especially in the initial phases or mild instances. Surgical procedures, while less frequently used now because of the increase in minimally invasive (MI) techniques, are still utilized in serious situations when other treatments do not work. This part serves a wide range of patients, providing options from basic preventive care to extensive surgical treatments.

Breakup by Procedure:

Injection Sclerotherapy

Endovenous Ablation

Surgical Ligation and Stripping

Injection sclerotherapy holds the largest share of the industry

A detailed breakup and analysis of the market based on the procedure have also been provided in the report. This includes injection sclerotherapy, endovenous ablation, and surgical ligation and stripping. According to the report, injection sclerotherapy accounted for the largest market share.

Injection sclerotherapy is the most dominant sector in the varicose vein treatment industry, mainly because of its effectiveness, low level of invasiveness, and cost-effectiveness. The process includes injecting a sclerosant solution into the varicose veins to irritate the vein walls, leading them to collapse and bond. As time passes, the vein that has been treated fades away as it gets absorbed back into the surrounding tissue. The popularity of sclerotherapy is enhanced by its ability to be performed in outpatient settings, its quick resolution of cosmetic concerns and discomfort from small varicose and spider veins, and its short recovery time, making it a preferred option for patients wanting both effectiveness and convenience. In 2023, the sclerotherapy market in the world was valued at US$ 1.2 billion. The IMARC Group projects that the market will expand at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, when it reaches US$ 2.0 billion in 2032.

Breakup by End User:

Hospitals

Clinics

Ambulatory Centers

Hospitals represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, clinics, and ambulatory centers. According to the report, hospitals represented the largest segment.

Hospitals dominate the market due to their extensive treatment options and ability to manage complicated cases that require advanced medical interventions, shaping a positive varicose vein treatment market outlook. They have the required infrastructure to offer various types of treatments for varicose veins, including less invasive procedures like sclerotherapy and endovenous ablation and more aggressive techniques such as surgical ligation and stripping. This section benefits a strong level of confidence from patients who are looking for dependable and efficient treatments from specialized vascular surgeons and interventional radiologists. Moreover, hospitals play a key role in are frequently the top choice for patients with advanced varicose veins who may need comprehensive care from various healthcare providers and extended monitoring, solidifying their position in the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest varicose vein treatment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for varicose vein treatment.

North America holds biggest share in the market, mainly due to substantial healthcare expenditure, cutting-edge medical technologies, and a solid healthcare system. This area, encompassing both the United States and Canada, shows a high need for minimally invasive (MI) procedures because of a high number of varicose veins in its elderly residents. As per the 2023 US Census Bureau report, the number of people in the US aged 65 and above was projected to increase by 47% from 58 million in 2022 to 82 million by 2050. Furthermore, it is expected that the percentage of people in this age range in the overall population will rise from 17% to 23%. Furthermore, North America is advantaged by having top healthcare firms and a strong regulatory framework that encourages quick uptake of new technologies. The strong presence of the region in the global market is also influenced by its extensive insurance coverage and high level of patient consciousness.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the industry include Alma Lasers Ltd. (Sisram Medical Ltd.), Angiodynamics Inc., Biolitec AG (BioMed Technology Holdings Ltd.), Boston Scientific Corporation, Eufoton S.R.L., Fotona, Medtronic plc, Sciton Inc., Teleflex Incorporated, The Vein Company, VVT Medical Ltd. and WON TECH Co. Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the market are working diligently on research and development (R&D) to improve the efficiency and safety of current treatments, as well as pursuing approval for new solutions. Leading varicose vein treatment companies are concentrating on broadening their range of products by forming strategic partnerships, merging, and acquiring other companies to strengthen their global market position. For example, DXI Capital Corp. revealed on November 24, 2023, its plan to acquire the entirety of V.V.T. Med Ltd. and Exiteam Acquisition Corp. through a non-binding letter of intent. This move was made to help DXI fulfill TSX Venture Exchange's listing criteria and sustain VVT's varicose vein treatment operations. Furthermore, there is a strong focus on marketing and educational initiatives to increase awareness about the progress in varicose vein treatments among both healthcare providers and patients. These initiatives focus on promoting the use of modern and less intrusive therapies, expanding the range of treatment choices in the market.

Varicose Vein Treatment Market News:

September 2023: The FDA approved ScleroSafe platform by VVT Medical for treating superficial varicose veins without using heat or tumescent methods. This gadget, approved in various areas, administers and removes substances at the same time using a dual syringe with a reverse action.

Key Questions Answered in This Report:

  • How has the global varicose vein treatment market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and varicose vein treatment market recent opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the market?
  • What is the breakup of the market based on the procedure?
  • Which is the most attractive procedure in the market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global varicose vein treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Varicose Vein Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Ablation Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Radiofrequency Ablation Devices
      • 6.1.2.2 Laser Ablation Devices
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Sclerotherapy Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure

  • 7.1 Injection Sclerotherapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endovenous Ablation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Surgical Ligation and Stripping
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Angiodynamics Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Biolitec AG (BioMed Technology Holdings Ltd.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Boston Scientific Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eufoton S.R.L.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Fotona
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sciton Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teleflex Incorporated
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Vein Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 VVT Medical Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 WON TECH Co. Ltd
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Varicose Vein Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Varicose Vein Treatment Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Varicose Vein Treatment Market: Breakup by Procedure (in %), 2023
  • Figure 6: Global: Varicose Vein Treatment Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Varicose Vein Treatment Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Varicose Vein Treatment (Ablation Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Varicose Vein Treatment (Ablation Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Varicose Vein Treatment (Sclerotherapy Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Varicose Vein Treatment (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Varicose Vein Treatment (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Varicose Vein Treatment (Injection Sclerotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Varicose Vein Treatment (Endovenous Ablation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Varicose Vein Treatment (Endovenous Ablation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Varicose Vein Treatment (Surgical Ligation and Stripping) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Varicose Vein Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Varicose Vein Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Varicose Vein Treatment (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Varicose Vein Treatment (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Varicose Vein Treatment (Ambulatory Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Varicose Vein Treatment (Ambulatory Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Varicose Vein Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Varicose Vein Treatment Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Varicose Vein Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Varicose Vein Treatment Industry: SWOT Analysis
  • Figure 76: Global: Varicose Vein Treatment Industry: Value Chain Analysis
  • Figure 77: Global: Varicose Vein Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Varicose Vein Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Varicose Vein Treatment Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Varicose Vein Treatment Market Forecast: Breakup by Procedure (in Million US$), 2024-2032
  • Table 4: Global: Varicose Vein Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Varicose Vein Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Varicose Vein Treatment Market: Competitive Structure
  • Table 7: Global: Varicose Vein Treatment Market: Key Players